ERBB2 and ovarian carcinoma: HER2 overexpression is associated with many cancers, including breast cancer [148], lung cancer [149], ovarian cancer [150] and gastric and esophageal carcinomas [151], and treatment targeting HER2 with antibodies is known [152,153].